Mini Review
Specific Treatment of Bone Metastases in Non-PC Urological Malignancies
Received Date: January 30, 2019; Published Date: February 13, 2019
Abstract
Bones are common site for metastatic development, in fact the third most common site of metastases, right after lungs and liver. This tendency is explained with its microenvironment – specifically bone marrow, that tends to facilitate “thriving” of certain types of metastatic cancer cells, which usually originate from prostate, breast and lung. Prostate cancer in particular has proclivity for development of osseous metastases, where we commonly find that the bones are the only site of its secondary deposits [1].
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Signup for Newsletter
